Medicare AdvantageCoverageMedium impact
MA06.002c, In Vitro Allergy Testing
Independence Blue Cross·Allergy & Immunology, Internal Medicine, Family Medicine +1 more·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA06.002c for In Vitro Allergy Testing has been reissued and will become effective April 1, 2026. This is a policy update that may contain changes to coverage criteria, billing requirements, or documentation standards for allergy testing procedures.
Action Required
Before April 1, 2026: Billing team must review the full MA06.002c policy document for In Vitro Allergy Testing to identify specific changes to coverage criteria, prior authorization requirements, or billing guidelines. Update billing procedures and staff training accordingly for Medicare Advantage plans.